Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?
Resource Type
Academic Journal
Authors
Roberts MJ; Royal Brisbane and Women's Hospital, Department of Urology, Brisbane, QLD, Australia. m.roberts2@uq.edu.au.; The University of Queensland, UQ Centre for Clinical Research, Brisbane, QLD, Australia. m.roberts2@uq.edu.au.; The University of Queensland, Faculty of Medicine, Brisbane, QLD, Australia. m.roberts2@uq.edu.au.; Yaxley JW; Royal Brisbane and Women's Hospital, Department of Urology, Brisbane, QLD, Australia.; The University of Queensland, Faculty of Medicine, Brisbane, QLD, Australia.; The Wesley Hospital, Brisbane, QLD, Australia.; Stranne J; Department of Urology, Institute of Clinical Science, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Urology, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.; van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.; Department of Urology, Koc University Hospital, Istanbul, Turkey.
Source
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE